Skip to content
Pharma Observatory a Scientist.com platform
  • Trial site

Trial site location from the registry's own city and country. GeoNames (geonames.org).

Clinical trial site

Stanford University

Stanford University in Stanford, California, United States is listed as a site for 952 registered clinical trials, 260 of them ongoing.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Registered trials 952
Ongoing 260

This page covers the site record Stanford University in Stanford, California, United States: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled. The organization of the same name, Stanford University, also sponsors trials.

Get the Stanford University report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Trials by phase

Registered trials that list this site, by trial phase. 952 trials counted.

  • Phase 1 99 trials
  • Phase 1/2 46 trials
  • Phase 2 154 trials
  • Phase 2/3 18 trials
  • Phase 3 102 trials
  • Phase 4 33 trials
  • Not applicable 342 trials
  • Observational 153 trials
  • Expanded access 5 trials

Trials by status

The registry's own status summary: Ongoing, Completed, Terminated or Other.

  • Ongoing 261 trials
  • Completed 535 trials
  • Terminated 124 trials
  • Other 32 trials

Trials over time

Trials registered with a start date in each year, 1990 onward, most recent years first.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational

Top of scale: 73

1994: 4 trials (Phase 3 3, Phase 1/2 1) 1996: 1 trials (Phase 3 1) 1997: 4 trials (Phase 3 2, Phase 2 1, Phase 1/2 1) 1998: 4 trials (Phase 3 1, Phase 2 3) 1999: 2 trials (Observational 1, Phase 3 1) 2000: 5 trials (Phase 3 1, Phase 2 2, Phase 1/2 1, Phase 1 1) 2001: 1 trials (Observational 1) 2002: 7 trials (Phase 3 2, Phase 2/3 1, Phase 2 2, Phase 1/2 2) 2003: 5 trials (Phase 4 1, Phase 3 1, Phase 2/3 1, Phase 2 1, Phase 1 1) 2004: 8 trials (Observational 2, Phase 3 2, Phase 2 3, Phase 1 1) 2005: 17 trials (Observational 2, Not applicable 2, Phase 4 2, Phase 3 3, Phase 2 4, Phase 1/2 2, Phase 1 2) 2006: 17 trials (Observational 3, Not applicable 3, Phase 3 3, Phase 2/3 2, Phase 2 3, Phase 1/2 1, Phase 1 2) 2007: 17 trials (Observational 4, Not applicable 2, Phase 3 6, Phase 2/3 1, Phase 2 3, Phase 1 1) 2008: 24 trials (Observational 5, Not applicable 1, Phase 4 7, Phase 3 2, Phase 2 5, Phase 1/2 1, Phase 1 3) 2009: 17 trials (Observational 4, Not applicable 1, Phase 4 1, Phase 3 5, Phase 2 4, Phase 1 2) 2010: 18 trials (Observational 1, Not applicable 3, Phase 3 4, Phase 2/3 1, Phase 2 8, Phase 1 1) 2011: 29 trials (Observational 8, Not applicable 11, Phase 3 1, Phase 2 6, Phase 1/2 1, Phase 1 2) 2012: 32 trials (Observational 8, Not applicable 8, Phase 3 4, Phase 2 6, Phase 1/2 1, Phase 1 5) 2013: 33 trials (Observational 5, Not applicable 8, Phase 3 5, Phase 2 11, Phase 1/2 1, Phase 1 3) 2014: 44 trials (Observational 6, Not applicable 20, Phase 4 1, Phase 3 1, Phase 2 7, Phase 1/2 1, Phase 1 8) 2015: 48 trials (Observational 13, Not applicable 14, Phase 4 2, Phase 3 5, Phase 2/3 2, Phase 2 7, Phase 1 5) 2016: 53 trials (Observational 11, Not applicable 20, Phase 4 2, Phase 3 4, Phase 2/3 1, Phase 2 5, Phase 1/2 3, Phase 1 7) 2017: 48 trials (Observational 11, Not applicable 20, Phase 4 4, Phase 3 7, Phase 2 3, Phase 1/2 1, Phase 1 2) 2018: 53 trials (Observational 9, Not applicable 24, Phase 4 2, Phase 3 4, Phase 2/3 1, Phase 2 6, Phase 1/2 2, Phase 1 5) 2019: 61 trials (Observational 12, Not applicable 27, Phase 4 2, Phase 3 3, Phase 2/3 2, Phase 2 8, Phase 1/2 4, Phase 1 3) 2020: 66 trials (Observational 13, Not applicable 20, Phase 4 1, Phase 3 11, Phase 2/3 2, Phase 2 8, Phase 1/2 3, Phase 1 8) 2021: 73 trials (Observational 9, Not applicable 27, Phase 4 1, Phase 3 4, Phase 2/3 1, Phase 2 17, Phase 1/2 2, Phase 1 12) 2022: 46 trials (Observational 7, Not applicable 22, Phase 4 1, Phase 3 2, Phase 2 6, Phase 1/2 5, Phase 1 3) 2023: 51 trials (Observational 2, Not applicable 29, Phase 3 4, Phase 2 10, Phase 1/2 2, Phase 1 4) 2024: 38 trials (Observational 5, Not applicable 14, Phase 4 2, Phase 3 2, Phase 2/3 2, Phase 2 3, Phase 1/2 6, Phase 1 4) 2025: 55 trials (Observational 6, Not applicable 31, Phase 4 1, Phase 3 6, Phase 2 4, Phase 1 7)

Trials that list this site and are registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2026 (partial year) 54
2025 55
2024 38
2023 51
2022 46
2021 73
2020 66
2019 61
2018 53
2017 48

Showing 10 of 32 years.

Start your 14-day trial Email me all 32 years as a PDF

2026 is partial: trials registered with a 2026 start date so far, not a full year. 6 trials are registered to start in 2027 or later, and not listed here

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

Showing 5 of 952 trials.

Start your 14-day trial Email me the first 50 trials as a PDF

Source: ClinicalTrials.gov

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Showing 5 of 203 lead sponsors.

Start your 14-day trial Email me the first 50 lead sponsors as a PDF

Conditions studied

The specific conditions of the trials that list this site, most trials first.

Showing 5 of 553 conditions.

Start your 14-day trial Email me the first 50 conditions as a PDF